12:00 AM
Jan 26, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Ex-RAD: Phase I started

Last month, Onconova began the double-blind, placebo-controlled, U.S. Phase I Ex-RAD 001 trial in healthy volunteers.


Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >